Focused Investors LLC Sells 10,800 Shares of Cigna Group $CI

Focused Investors LLC cut its holdings in shares of Cigna Group (NYSE:CIFree Report) by 1.5% during the first quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 698,200 shares of the health services provider’s stock after selling 10,800 shares during the period. Cigna Group comprises approximately 6.1% of Focused Investors LLC’s holdings, making the stock its 4th largest holding. Focused Investors LLC’s holdings in Cigna Group were worth $186,245,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors have also recently bought and sold shares of the company. BI Asset Management Fondsmaeglerselskab A S raised its position in Cigna Group by 99.2% in the 1st quarter. BI Asset Management Fondsmaeglerselskab A S now owns 35,118 shares of the health services provider’s stock valued at $9,368,000 after purchasing an additional 17,488 shares during the last quarter. Genesis Private Wealth LLC grew its holdings in shares of Cigna Group by 87.5% during the first quarter. Genesis Private Wealth LLC now owns 1,641 shares of the health services provider’s stock worth $438,000 after purchasing an additional 766 shares during the last quarter. Stance Capital LLC bought a new stake in shares of Cigna Group during the fourth quarter worth $2,881,000. Rockefeller Capital Management L.P. increased its stake in shares of Cigna Group by 1.4% in the fourth quarter. Rockefeller Capital Management L.P. now owns 47,499 shares of the health services provider’s stock valued at $13,073,000 after buying an additional 644 shares in the last quarter. Finally, Hsbc Holdings PLC increased its stake in shares of Cigna Group by 67.2% in the fourth quarter. Hsbc Holdings PLC now owns 1,019,925 shares of the health services provider’s stock valued at $281,410,000 after buying an additional 409,894 shares in the last quarter. 86.99% of the stock is owned by institutional investors and hedge funds.

Cigna Group Trading Up 0.1%

CI stock opened at $279.63 on Monday. The company has a market cap of $73.97 billion, a P/E ratio of 11.85, a PEG ratio of 1.08 and a beta of 0.28. Cigna Group has a twelve month low of $239.51 and a twelve month high of $338.89. The company has a quick ratio of 0.73, a current ratio of 0.73 and a debt-to-equity ratio of 0.69. The business has a fifty day moving average of $283.79 and a 200-day moving average of $278.36.

Cigna Group (NYSE:CIGet Free Report) last issued its quarterly earnings results on Thursday, April 30th. The health services provider reported $7.79 earnings per share (EPS) for the quarter, beating the consensus estimate of $7.60 by $0.19. The business had revenue of $68.52 billion for the quarter, compared to analyst estimates of $66.29 billion. Cigna Group had a return on equity of 19.75% and a net margin of 2.26%.The firm’s revenue for the quarter was up 4.6% compared to the same quarter last year. During the same quarter in the prior year, the firm posted $6.74 earnings per share. Cigna Group has set its FY 2026 guidance at 30.350- EPS. As a group, equities research analysts expect that Cigna Group will post 30.39 EPS for the current year.

Cigna Group Announces Dividend

The firm also recently announced a quarterly dividend, which was paid on Thursday, June 18th. Shareholders of record on Thursday, June 4th were given a dividend of $1.56 per share. The ex-dividend date was Thursday, June 4th. This represents a $6.24 dividend on an annualized basis and a yield of 2.2%. Cigna Group’s dividend payout ratio is presently 26.45%.

Insider Transactions at Cigna Group

In related news, CEO David Cordani sold 201,878 shares of the business’s stock in a transaction that occurred on Tuesday, May 12th. The shares were sold at an average price of $292.82, for a total transaction of $59,113,915.96. Following the completion of the sale, the chief executive officer directly owned 34,337 shares of the company’s stock, valued at $10,054,560.34. The trade was a 85.46% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available at this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CAO Jamie G. Kates sold 899 shares of the business’s stock in a transaction that occurred on Friday, June 12th. The stock was sold at an average price of $298.61, for a total transaction of $268,450.39. Following the sale, the chief accounting officer directly owned 2,368 shares of the company’s stock, valued at approximately $707,108.48. This trade represents a 27.52% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Corporate insiders own 0.60% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of research analysts recently issued reports on CI shares. Royal Bank Of Canada lifted their price target on Cigna Group from $333.00 to $337.00 and gave the company an “outperform” rating in a report on Friday, May 1st. Cantor Fitzgerald increased their price objective on shares of Cigna Group from $325.00 to $340.00 and gave the stock an “overweight” rating in a report on Friday, May 1st. Deutsche Bank Aktiengesellschaft cut shares of Cigna Group from a “buy” rating to a “hold” rating and lowered their price objective for the company from $303.00 to $302.00 in a research report on Wednesday, May 20th. Raymond James Financial set a $340.00 target price on shares of Cigna Group in a research note on Friday, May 1st. Finally, Mizuho upped their target price on shares of Cigna Group from $330.00 to $340.00 and gave the stock an “outperform” rating in a research report on Monday, June 8th. One analyst has rated the stock with a Strong Buy rating, fifteen have given a Buy rating and six have given a Hold rating to the stock. According to data from MarketBeat.com, the company currently has an average rating of “Moderate Buy” and a consensus price target of $338.30.

View Our Latest Report on CI

Cigna Group Company Profile

(Free Report)

Cigna Group (NYSE: CI) is a global health services company that offers a broad portfolio of healthcare products and insurance solutions for individuals, employers, and governments. Its core businesses include medical and behavioral health plans, dental and vision coverage, pharmacy benefit management, and supplemental health products. Cigna serves a mix of commercial, Medicare, and Medicaid customers and provides workplace benefits such as group health plans and disability and life benefits for employers.

In addition to traditional insurance products, Cigna operates health services and care-delivery platforms designed to manage costs and improve outcomes.

Featured Articles

Want to see what other hedge funds are holding CI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cigna Group (NYSE:CIFree Report).

Institutional Ownership by Quarter for Cigna Group (NYSE:CI)

Receive News & Ratings for Cigna Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cigna Group and related companies with MarketBeat.com's FREE daily email newsletter.